packaging
pack of 1 ea
manufacturer/tradename
Cytiva RPN3004
storage temp.
2-8°C
General description
The world’s first commercially available chemiluminescent detection reagent for Western blotting. Amersham ECL detection reagent uses enhanced luminol-based detection suitable for all routine confirmatory Western blotting experiments.
Based on the enhanced chemiluminescent reaction of luminol with horseradish peroxidase, ECL substrate can be used to detect probes which have been labelled either directly or indirectly with horseradish peroxidase. Rapid light output enables results to be achieved in 10 to 15 minutes. It is the substrate of choice for target amounts above 500 fg.
High sensitivity and fast results:
Based on the enhanced chemiluminescent reaction of luminol with horseradish peroxidase, ECL substrate can be used to detect probes which have been labelled either directly or indirectly with horseradish peroxidase. Rapid light output enables results to be achieved in 10 to 15 minutes. It is the substrate of choice for target amounts above 500 fg.
High sensitivity and fast results:
- Detects up to 10 to 12 ng of protein, which is ~10× more than colorimetric methods
- Optimized to use with Amersham Protran nitrocellulose (NC) membranes
- Delivers results in just a few minutes, then image using a CCD imager like the Amersham ImageQuant 800 or Amersham Hyperfilm ECL
Preparation Note
Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.
Analysis Note
To view the Certificate of Analysis for this product, please visit www.cytiva.com.
Legal Information
ECL is a trademark of Cytiva
存储类别
12 - Non Combustible Liquids
法规信息
新产品
此项目有
商品
描述被分子生物学家用于检测转印膜上蛋白质和核酸的方法的背景和实验方案。
Background and protocols describing the various methods used by molecular biologists to detect samples of protein or nucleic acids bound to membranes.
C Couturier et al.
Arteriosclerosis, thrombosis, and vascular biology, 20(12), 2559-2565 (2000-12-16)
Type II secreted phospholipase A(2) (sPLA(2)) releases precursors of important inflammatory lipid mediators from phospholipids. Some observations have indicated that the sPLA(2), which has been implicated in chronic inflammatory conditions such as arthritis, contributes to atherosclerosis in the arterial wall.
H M Peng et al.
Molecular pharmacology, 54(4), 740-747 (1998-10-10)
The regulation of cytochrome P450 (CYP) 2E1, the ethanol-inducible isoform, is particularly complex. The level is affected by a variety of other foreign compounds, by insulin (as studied in several laboratories), and by triiodothyronine (T3), which has not been previously
C Couturier et al.
The Journal of biological chemistry, 274(33), 23085-23093 (1999-08-07)
Type II-secreted phospholipase A(2) (type II-sPLA(2)) is expressed in smooth muscle cells during atherosclerosis or in response to interleukin-1beta. The present study shows that the induction of type II-sPLA(2) gene by interleukin-1beta requires activation of the NFkappaB pathway and cytosolic
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| GERPN3004 | 04061834085164 |